RA PHARMACEUTICALS, INC. Earnings Per Share, Basic and Diluted
RA PHARMACEUTICALS, INC. reported Earnings Per Share, Basic and Diluted of -$0.79 per share for the 3-month period ending 2019-12-31, per its 10-K filed 2020-02-27.
Discontinued › Income Statement › Earnings Per Share
us-gaap:EarningsPerShareBasicAndDiluted · last filed 2020-02-27
- RA PHARMACEUTICALS, INC. earnings per share, basic and diluted for the quarter ending 2019-12-31 was -$0.79.
- RA PHARMACEUTICALS, INC. earnings per share, basic and diluted for the quarter ending 2019-09-30 was -$0.55.
- RA PHARMACEUTICALS, INC. earnings per share, basic and diluted for the quarter ending 2019-06-30 was -$0.52.
- RA PHARMACEUTICALS, INC. earnings per share, basic and diluted for the quarter ending 2019-03-31 was -$0.45.
- RA PHARMACEUTICALS, INC. earnings per share, basic and diluted for fiscal 2019 was -$2.31.
- RA PHARMACEUTICALS, INC. earnings per share, basic and diluted for fiscal 2018 was -$2.06.
- RA PHARMACEUTICALS, INC. earnings per share, basic and diluted for fiscal 2017 was -$2.41.
- RA PHARMACEUTICALS, INC. earnings per share, basic and diluted for fiscal 2016 was -$6.98.
| Period end | Earnings Per Share, Basic and Diluted 3 month | Earnings Per Share, Basic and Diluted 6 month | Earnings Per Share, Basic and Diluted 9 month | Earnings Per Share, Basic and Diluted 12 month |
|---|---|---|---|---|
| 2019-12-31 | -$0.79 10-K · filed 2020-02-27 | -$2.31 10-K · filed 2020-02-27 | ||
| 2019-09-30 | -$0.55 10-K · filed 2020-02-27 | -$1.52 10-Q · filed 2019-11-07 | ||
| 2019-06-30 | -$0.52 10-K · filed 2020-02-27 | -$0.97 10-Q · filed 2019-08-07 | ||
| 2019-03-31 | -$0.45 10-K · filed 2020-02-27 | |||
| 2018-12-31 | -$0.47 10-K · filed 2020-02-27 | -$2.06 10-K · filed 2020-02-27 | ||
| 2018-09-30 | -$0.51 10-K · filed 2020-02-27 | -$1.60 10-Q · filed 2019-11-07 | ||
| 2018-06-30 | -$0.49 10-K · filed 2020-02-27 | -$1.08 10-Q · filed 2019-08-07 | ||
| 2018-03-31 | -$0.61 10-K · filed 2020-02-27 | |||
| 2017-12-31 | -$0.67 10-K · filed 2019-03-07 | -$1.34 derived: net income ÷ weighted average shares · filed 2019-03-07 | -$1.91 derived: net income ÷ weighted average shares · filed 2019-03-07 | -$2.41 10-K · filed 2019-03-07 |
| 2017-09-30 | -$0.68 10-K · filed 2019-03-07 | -$1.24 derived: net income ÷ weighted average shares · filed 2019-03-07 | -$1.74 10-Q · filed 2018-11-07 | -$2.43 derived: net income ÷ weighted average shares · filed 2019-03-07 |
| 2017-06-30 | -$0.56 10-K · filed 2019-03-07 | -$1.06 10-Q · filed 2018-08-08 | -$1.75 derived: net income ÷ weighted average shares · filed 2019-03-07 | -$2.84 derived: net income ÷ weighted average shares · filed 2019-03-07 |
| 2017-03-31 | -$0.50 10-K · filed 2019-03-07 | -$1.19 derived: net income ÷ weighted average shares · filed 2019-03-07 | -$2.40 derived: net income ÷ weighted average shares · filed 2019-03-07 | -$3.66 derived: net income ÷ weighted average shares · filed 2019-03-07 |
| 2016-12-31 | -$0.73 10-K · filed 2018-03-14 | -$2.47 derived: net income ÷ weighted average shares · filed 2018-03-14 | -$4.48 derived: net income ÷ weighted average shares · filed 2018-03-14 | -$6.98 10-K · filed 2018-03-14 |
| 2016-09-30 | -$14.22 10-K · filed 2018-03-14 | -$23.26 derived: net income ÷ weighted average shares · filed 2018-03-14 | -$32.73 10-Q · filed 2017-11-09 | -$41.42 derived: net income ÷ weighted average shares · filed 2018-03-14 |
| 2016-06-30 | -$8.90 10-K · filed 2018-03-14 | -$18.32 10-Q · filed 2017-08-09 | -$26.95 derived: net income ÷ weighted average shares · filed 2018-03-14 | -$31.78 derived: net income ÷ weighted average shares · filed 2018-03-14 |
| 2016-03-31 | -$9.42 10-K · filed 2018-03-14 | -$18.06 derived: net income ÷ weighted average shares · filed 2018-03-14 | -$22.85 derived: net income ÷ weighted average shares · filed 2018-03-14 | -$28.11 derived: net income ÷ weighted average shares · filed 2018-03-14 |
| 2015-12-31 | -$8.63 10-K · filed 2017-03-06 | -$13.34 derived: net income ÷ weighted average shares · filed 2017-03-06 | -$18.53 derived: net income ÷ weighted average shares · filed 2017-03-06 | -$24.68 10-K · filed 2018-03-14 |
| 2015-09-30 | -$4.57 10-K · filed 2017-03-06 | -$9.70 derived: net income ÷ weighted average shares · filed 2017-03-06 | -$15.84 10-Q · filed 2016-11-29 | |
| 2015-06-30 | -$5.14 10-K · filed 2017-03-06 | -$11.29 derived: net income ÷ weighted average shares · filed 2017-03-06 | ||
| 2015-03-31 | -$6.16 10-K · filed 2017-03-06 | |||
| 2014-12-31 | -$12.46 10-K · filed 2017-03-06 |